PCOL (VIOLET) Flashcards
PACOP
Mechanism of action of local anesthetics.
A. Block sodium channel thereby stopping axonal conduction
B. Block alpha and beta receptor
C. Block neuronal firing by decreasing Ach in the neuromuscular junction
D. Inhibition of acetyl cholinesterase enzyme
E. Inhibition of enzyme responsible for pain response
A.
The following are factors that affect the absorption of drug from the gastrointestinal(GI)
track except.
A. Surface area of absorption
B. Blood flow to the site of absorption
C. Physical state of the drug
D. Concentration of the drug at the site of absorption
E. Protein binding
E.
Continued stimulation of cells with agonists generally results in which of the following?
A. Desensitization
B. UP-regulation
C. Down-regulation
D. A and B
E. A and C
E.
Drug that lacks intrinsic efficacy but retains affinity and competes with the agonist for the
binding sites of the receptor.
A. Competitive antagonist
B. Full agonist
C. Non-competitive antagonist
D. Partial antagonist
E. Partial agonist
A.
This type of drug produce its effect by binding a site on the receptor distinct from that of the primary agonist and thereby changing the affinity of the receptor for the agonist.
A. Competitive antagonist
B. Full agonist
C. Non-competitive antagonist
D. Partial antagonist
E. Partial agonist
C
In this type of study, participants are blinded to treatment assignment, investigator are not.
A. Double blind study
B. Single blind study
C. Masking
D. Open-label
E. Un-blinded study
B
The neurotransmitter of all preganglionic autonomic fibers, and all postganglionic
parasympathetic fibers.
A. Norepinephrine
B. Noradrenaline
C. Acetylcholine
D. A and B
E. A and C
C
The release of ach and other neurotransmitters by exocytosis is inhibited by:
A. Acetylcholinesterase
B. Botulinum toxin
C. Reserpine
D. Me tyrosine
E. Guanethidine
B
All of the following are enzymes involved in the biosynthesis of epinephrine from tyrosine
EXCEPT:
A. Tyrosine hydroxylase
B. Aromatic L amino acid decarboxylase
C. Dopamine Beta-hydroxylase
D. Phenyl ethanolamine-N-Methyl transferase
E. Monoamine oxidase
E
Rate limiting enzyme in the synthesis of catecholamines
A. Tyrosine hydroxylase
B. Aromatic L-amino acid decarboxylase
C. Dopamine beta-hydroxylase
D. Phenyl ethanolamine-N-Methyl transferase
E. COMT
A
All of the following are effects of activating beta 2 receptor EXCEPT:
A. Bronchoconstriction
B. Uterine Relaxation
C. Glycogenolysis
D. Gluconeogenesis
E. Bronchodilation
A
All of the following are effects of activating alpha 1 receptor EXCEPT:
A. Vascular smooth muscle relaxation
B. Intestinal smooth muscle relaxation
C. Increase contractive force of the heart
D. Glycogenolysis in the liver
E. Vascular smooth muscle constriction
A
Which of the following is a pharmacological effect of muscarinic stimulation in the
cardiovascular system?
A. Vasoconstriction
B. Decrease in cardiac rate
C. Positive chronotropic effect
D. Positive dromotropic effect
E. Positive inotropic effect
B
All of the following are naturally occurring chromonematic Alkaid EXCEPT:
A. Pilocarpine
B. Muscarine
C. Acetylcholine
D. Arecoline
E. None of these
C
Which of the following is/are effects of cholinomimetic drugs?
I. Stimulation of GI smooth muscle
II. Stimulation of secretion of exocrine gland
III. Bronchoconstriction
IV. Tachycardia
A. I and II
B. II and III
C. I, II and III
D. I and IV
E. I, II, III and IV
C
Major contraindication to the use of muscarinic agonist are the following EXCETP:
A. Asthma
B. Hypothyroidism
C. Coronary insufficiency
D. Acid-peptic disease
E. Hypertension
E
Used in the treatment of glaucoma where it is instilled into the eye usually as a 0.5-4%
solution.
A. Epinephrine
B. Eye-mo
C. Pilocarpine
D. Bethanecole
E. Atropine
C
Most effective prophylactic agent for short (4-6 hrs) exposure to severe motion also
available as transdermal patch.
A. Atropine
B. Scopolamine
C. Ipratropium
D. Tiotropium
E. Varenicline
B
Which of the following drugs is/are classified an acetylcholinesterase inhibitor?
I. Pilocarpine
II. Edrophonium
III. Tacrine
IV. Atropine
A. I only
B. I and II
C. II and III
D. I, II and III
E. IV only
C
Which of the following is not an effect of anti-cholinesterase agents?
A. Stimulation of muscarinic receptor responses at autonomic effector organs
B. Stimulation followed by depression or paralysis of all autonomic ganglia and skeletal
muscle
C. Stimulation with occasional subsequent depression of cholinergic receptor sites in the
CNS
D. All of these
E. None of these
E
. Intoxication with an organophosphorus anti-cholinesterase agent can be treated with:
A. Atropine
B. Pralidoxime
C. Malathion
D. A and B
E. B and C
D
This agent is used in the diagnosis of myasthenia gravis.
A. Edrophonium
B. Atropine
C. Neostigmine
D. Pralidoxime
E. Acetylcholine
A
All are standard anti-cholinesterase drugs used in the symptomatic treatment of myasthenia
gravis EXCPT:
A. Pyridostigmine
B. Neostigmine
C. Atropine
D. Ambenonium
E. Edrophonium
C
Mechanism of action of indirect acting sympathomimetics drugs:
A. Agents act directly on one or more of the adrenergic receptors thereby producing an
effect
B. Increase the availability of norepinephrine (NE) or epinephrine (Epi) to stimulate
adrenergic receptors
C. Releasing or displacing NE from sympathetic nerve varicosities
D. A and B
E. B and C
E